FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Combivent Respimat (ipratropium bromide and albuterol) from Boehringer Ingelheim Pharmaceuticals, Inc., indicating a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• Combivent Respimat (ipratropium bromide and albuterol sulfate)

Snippet

SUPPL AP for COMBIVENT RESPIMAT (IPRATROPIUM BROMIDE AND ALBUTEROL)